An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. – PubMed – NCBI
Real Medical Cannabis Research Wanted Here…..
Here’s a new NIH.GOV study (i.e., one of those peer-reviewed scientific studies the UMA can’t seem to find) showing medical cannabis showing promising results in helping in the “treatment of Neuropathic Pain From Spinal Cord Injury and Disease.”
Please note that it’s a study which could NOT have been done in Utah under the HB130, the “Cannabinoid Research” act, because that act prohibits research on whole plant, and doesn’t include vaporized cannabis as an acceptable form of medicine, despite many studies validating it as useful – and much faster acting than orally ingested preparations or any other form specified in HB130.
While UT’s first priority is for safe, legal access via a patient PROGRAM, we secondarily welcome Medical CANNABIS Research – however – it’s distressing that ours will be confined to a restricted, made up, walled-off, political category called “Cannabinoid Research.”
The distinction is much more important than it may at first seem. As we see it, this feels less like a move TOWARD legal medical cannabis, and more a move away. Any research program worth its scientific salt should allow the study of the full benefit of whole plant medicine, a form allowed in all 28 legal states.
TRUCE in consultation with other groups and orgs follows the news nationwide, and know many factors in play discerning citizens will want to start weighing on their own, e.g……
…We often note only a coalition of activists and traditionalists will garner enough support for a UT initiative… …but this is only one reason we discourage LDS and Republican bashing on our forums (and why TRUCE is proud of our religious and ideological diversity)…..
…rather another EMERGING reason bearing consideration is that as the cannabis product industry grows rapidly, we see the general evolution of former opponents being open to “limited reforms,” seemingly complementing a commercial strategy that fits the interests of particular pharmaceutical interests – interests who are developing patentable, proprietary cannabinoid derivatives – generally low in THC – and who would like to make these products the only (and expensive) agents available in remaining non-MC states.
If such an alliance were to be successfully enabled by legislative action (and HB130 is a “definitional step” in that direction), then, this would serve both these companies and the interests the die-hard cultural opponents of the cannabis plant.
…Leaving “everyone” – well everyone except patients and people who accept the preponderance of the evidence – and a majority of the people of the state – “happy” in this “Cannabinoid Medicine” script.
We advise always questioning who’s really on the sides of patients if they don’t support whole plant medicine.
#MMJ #Research #Pain #Spine #UTpol #Cannabinoid #TRUCE